1 郑瑞丹,陈建能.妊娠期肝内胆汁淤积症诊治进展.中国医学前沿杂志(电子版),2015,4:14-18. 2 Castano G,Lucangioli S,Sookoian S,et al.Bile acid profiles by capillary electrophoresis in intrahepatic cholestasis of pregnancy.Clin Sci (Lond),2006,110:459-465. 3 Pineda TI,Claudel T,Duval C,et al.Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid x receptor.Mol Endocrinol,2003,17:259-272. 4 Ma K,Saha PK,Chan L,et al.Farnesoid x receptor is essential for normal glucose homeostasis.J Clin Invest,2006,116:1102-1109. 5 Dann AT,Kenyon AP,Wierzbicki AS,et al.Plasma lipid profiles of women with intrahepatic cholestasis of pregnancy.Obstet Gynecol,2006,107:106-114. 6 Wikstrom SE,Marschall HU,Ludvigsson JF,et al.Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes:a 12-year population-based cohort study.BJOG,2013,120:717-723. 7 Wrann CD,White JP,Salogiannnis J,et al.Exercise induces hippocampal bdnf through a pgc-1α/fndc5 pathway.Cell Metab,2013,18:649-659. 8 Boström P,Wu J,Jedrychowski MP,et al.A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis.Nature,2012,481:463-468. 9 Ivanov IP,Firth AE,Michel AM,et al.Identification of evolutionarily conserved non-AUG-initiated N-terminal extensions in human coding sequences.Nucleic Acids Res,2011,39:4220-4234. 10 Silja R,Manuela E,Hans G,et al.Evidence against a beneficial effect of irisin in humans.PloS one,2013,8:1-12. 11 Gamas L,Matafome P,Seiça R.Irisin and myonectin regulation in the insulin resistant muscle:implications to adipose tissue:muscle crosstalk.J Diabetes Res,2015,2015:1-8. 12 Moreno-Navarrete JM,Ortega F,Serrano M,et al.Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance.J Clin Endocrin Metab,2013,98:E769-E778. 13 Huh JY,Panagiotou G,Mougios V,et al.Fndc5 and irisin in humans:i.Predictors of circulating concentrations in serum and plasma and ii.Mrna expression and circulating concentrations in response to weight loss and exercise.Metabolism,2012,61:1725-1738. 14 Usluogullari B,Usluogullari CA,Balkan F,et al.Role of serum levels of irisin and oxidative stress markers in pregnant women with and without gestational diabetes.Gynecol Endocrinol,2017,33:405-407. 15 孙立峰,薛丽,杨雅莉,等.鸢尾素(irisin)与能量代谢相关研究进展.生理科学进展,2017,48:409-416. 16 Askari H,Rajani SF,Poorebrahim M,et al.A glance at the therapeutic potential of irisin against diseases involving inflammation,oxidative stress,and apoptosis:an introductory review.Pharmacol Res,2018,129:44-55. 17 Garces MF,Peralta JJ,Ruiz-Linares CE,et al.Irisin levels during pregnancy and changes associated with the development of preeclampsia.J Clin Endocrinol Metab,2014,99:2113-2119. 18 Du XL,Jiang WX,Lv ZT.Lower circulating irisin level in patients with diabetes mellitus:a systematic review and meta-analysis.Horm Metab Res,2016,48:644-652. 19 Yuksel MA,Oncul M,Tuten A,et al.Maternal serum and fetal cord blood irisin levels in gestational diabetes mellitus.Diabetes Res Clin Pract,2014,104:171-175. 20 Kirbas A,Daglar K,Timur H,et al.Maternal circulating levels of irisin in intrahepatic cholestasis of pregnancy.J Matern Fetal Neonatal Med,2016,29:3483-3487. 21 Ebert T,Stepan H,Schrey S,et al.Serum levels of irisin in gestational diabetes mellitus during pregnancy and after delivery.Cytokine,2014,65:153-158. 22 Liu TY,Shi CX,Gao R,et al.Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/AKT pathway in type 2 diabetic mice and hepatocytes.Clin Sci (Lond),2015,129:839-850. 23 Xin C,Liu J,Zhang J,et al.Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the ampk signaling pathway.Int J Obes (Lond),2016,40:443-451. 24 Bennion LJ,Grundy SM.Effects of diabetes mellitus on cholesterol metabolism in man.N Engl J Med,1977,296:1365-1371. 25 Herrema H,Meissner M,van Dijk TH,et al.Bile salt sequestration induces hepaticde novo lipogenesis through farnesoid x receptor- and liver x receptorα-controlled metabolic pathways in mice.Hepatology,2010,51:806-816. 26 Martineau M,Raker C,Powrie R,et al.Intrahepatic cholestasis of pregnancy is associated with an increased risk of gestational diabetes.Eur J Obstet Gynecol Reprod Biol,2014,176:80-85. 27 Martineau MG,Raker C,Dixon PH,et al.The metabolic profile of intrahepatic cholestasis of pregnancy is associated with impaired glucose tolerance,dyslipidemia,and increased fetal growth.Diabetes Care,2015,38:243-248. 28 Fiorucci S,Mencarelli A,Palladino G,et al.Bile-acid-activated receptors:targeting TGR5 and farnesoid-x-receptor in lipid and glucose disorders.Trends Pharmacol Sci,2009,30:570-580. 29 Fiorucci S,Mencarelli A Palladino G.Advances in bile acid medicinal chemistry.Curr Med Chem,2011,18:4029-4052. 30 Gao S,Li F,Li H,et al.Effects and molecular mechanism of GST-irisin on lipolysis and autocrine function in 3T3-L1 adipocytes.PLOS ONE,2016,11:1-15. 31 Xiong XQ,Chen D,Sun HJ,et al.FNDC5 overexpression and irisin ameliorate glucose/lipid metabolic derangements and enhance lipolysis in obesity.Biochim Biophys Acta,2015,1852:1867-1875. 32 Huh J Y,Dincer F,Mesfum E,et al.Irisin stimulates muscle growth-related genes and regulates adipocyte differentiation and metabolism in humans.Int J Obes (Lond),2014,38:1538-1544. 33 Tang H,Yu R,Liu S,et al.Irisin inhibits hepatic cholesterol synthesis via AMPK-srebp2 signaling.EBioMedicine,2016,6:139-148. 34 Park KH,Zaichenko L,Brinkoetter M,et al.Circulating irisin in relation to insulin resistance and the metabolic syndrome.J Clin Endocrin Metab,2013,98:1-10. 35 Moreno M,Moreno-Navarrete JM,Serrano M,et al.Circulating irisin levels are positively associated with metabolic risk factors in sedentary subjects.PLOS ONE,2015,10:1-11. 36 Tang S,Zhang R,Jiang F,et al.Circulating irisin levels are associated with lipid and uric acid metabolism in a Chinese population.Clin Exp Pharmacol Physiol,2015,42:896-901. 37 Jang H B,Kim H J,Kang J H,et al.Association of circulatingirisin levels with metabolic and metabolite profiles of Korean adolescents.Metabolism,2017,73:100-108. 38 Panagiotou G,Mu L,Na B,et al.Circulating irisin,omentin-1,and lipoprotein subparticles in adults at higher cardiovascular risk.Metabolism,2014,63:1265-1271. 39 Oelmann S,Nauck M,Völzke H,et al.Circulating irisin concentrations are associated with a favourable lipid profile in the general population.PLOS ONE,2016,11:1-12. 40 Mehrabian S,Taheri E,Karkhaneh M,et al.Association of circulating irisin levels with normal weight obesity,glycemic and lipid profile.J Diabetes Metab Disord,2015,15:1-6. 41 Anastasilakis A D,Polyzos S A,Saridakis Z G,et al.Circulating irisin in healthy,young individuals:day-night rhythm,effects of food intake and exercise,and associations with gender,physical activity,diet,and body composition.J Clin Endocrinol Metab,2014,99:3247-3255. 42 Gouniberthold I,Berthold H K,Huh J Y,et al.Effects of lipid-lowering drugs on irisin in human subjects in vivo and in human skeletal muscle cells ex vivo.PLOS ONE,2013,8:1-10. 43 Teodoro JS,Zouhar P,Flachs P,et al.Enhancement of brown fat thermogenesis using chenodeoxycholic acid in mice.Int J Obes(Lond),2014,38:1024-1037. 44 Watanabe M,Houten SM,Mataki C,et al.Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation.Nature,2006,439:484-489. 45 Fang S,Suh JM,Reilly SM,et al.Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance.Nat Med,2015,21:159-165. 46 Liu S,Du F,Li X,et al.Effects and underlying mechanisms of irisin on the proliferation and apoptosis of pancreatic β cells.PLOS ONE,2017,12:1-12. 47 Mella MT,Kohari K,Jones R,et al.Mitochondrial gene expression profiles are associated with intrahepatic cholestasis of pregnancy.Placenta,2016,45:16-23. 48 Mazur-Bialy AI,Bilski J,Pochec E,et al.New insight into the direct anti-inflammatory activity of a myokine irisin against proinflammatory activation of adipocytes.Implication for exercise in obesity.J Physiol Pharmacol,2017,68:243-251. 49 Dong J,Dong Y,Dong Y,et al.Inhibition ofmyostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues.Int J Obes (Lond),2016,40:434-442. 50 Park M,Kim D,Choi J,et al.New role ofirisin in hepatocytes:the protective effect of hepatic steatosis in vitro.Cell Signal,2015,27:1831-1839. 51 Zhang Y,Pan Y,Lin C,et al.Bile acids evoke placental inflammation by activating Gpbar1/NF-κb pathway in intrahepatic cholestasis of pregnancy.J Mol Cell Biol,2016,8:530-541.
